The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.

null nullChristopher Wood Victoria Speed Louis Fisher Helen J Curtis Andrea L Schaffer Alex J Walker Richard Croker Andrew D Brown Christine Cunningham William J Hulme Colm D AndrewsBen F C Butler-ColeDavid Evans Peter InglesbyIain DillinghamSebastian C J Bacon Simon Davy Tom Ward George Hickman Lucy Bridges Thomas O'Dwyer Steven MaudeRebecca M SmithAmir Mehrkar Christopher Bates Jonathan CockburnJohn ParryFrank HesterSam HarperAlex J Walker Brian Mackenna

Published in: British journal of clinical pharmacology (2024)

There was a substantial reduction in the monthly rate of medication reviews during the pandemic but rates recovered by the end of the study period. Structured medication reviews were prioritized for high-risk patients.

Keyphrases

electronic health record
adverse drug
primary care
coronavirus disease
sars cov
end stage renal disease
healthcare
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
emergency department
patient reported outcomes
patient reported